Default company panoramic image
C8be1da1 32d2 4458 a432 de23caf950a0

GenomeRx, LLC

A genomic test for early diagnosis of head and neck cancer, prognosis of recurrence and recommendation of therapy for effective treatment.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Kirkland, WA, USA
  • Currency USD
  • Founded April 2011
  • Employees 1
  • Website

Company Summary

GenomeRx is an early stage clinical diagnostic company focused on improving the lives of cancer patients by early diagnosis of cancer, predicting patients with more likelihood of acquiring cancer, and likelihood of recurrence and response to chemo- or radiotherapy for cancer patients after surgery. The primary focus of GenomeRx is to help Head and Neck Squamous Cell Carcinoma (HNSCC) patients. We plan to launch the product in the 3rd year.


  • Default avatar
    Narendra Vaish, PhD, MBA
    President and CSO

    Dr. Vaish brings more than 15 years of drug discovery and diagnostic experience. He was instrumental in establishing founding allosteric ribozyme technologies for nucleic acids and protein detection at Ribozyme Pharmaceuticals. He also developed founding siRNA drug discovery platforms at Sirna Therapeutics and at Marina Biotech. Dr. Vaish has >150 patents or patent applications pending on various genes, diagnostic and therapeutic technologies.

  • 2a6872b4 1dc5 4601 9e14 40982d3897eb
    Scientific Consultant

    Developmental Biologist trained at Harvard Medical and Dental School with more than 12 years experience in the field of genetics and Developmental biology

  • Dr. Agarwal is a highly qualified pathologist who brings in many years of translational research and pathology experience in the fields of HNSCC, breast cancer and lymphomas. Dr. Agarwal has extensive experience in both neoplastic and non-neoplastic pathology in the eastern and western world and also well versed with animal histopathology.


  • Default avatar
    Richard Eckman, PhD, JD
    Default avatar
    Isaac Koll, CPA